Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
7d
News-Medical.Net on MSNTirzepatide helps people without diabetes lose 13% body weight in real-world studyA real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
Chuck E. Cheese has recently overhauled its brand, bringing major changes to its nearly 500 locations that longtime visitors might be surprised to see. The biggest? The removal of its iconic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results